Position in ABBV
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$10,640,343
+$1,772,408 QoQ
Shares Held
42,284
+3.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#893
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ballentine Partners, LLC holds $83,408,432 across 14 Drug Manufacturers - General names. ABBV ranks #3 (12.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,150 | $24,168,514 | |
| 2 | JNJ |
Johnson & Johnson
|
66,025 | $16,768,367 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
42,284 | $10,640,343 | |
| 4 | MRK |
Merck & Co., Inc.
|
52,463 | $6,741,493 | |
| 5 | NVS |
Novartis AG
|
29,508 | $4,624,493 | |
| 6 | AZN |
Astrazeneca PLC
|
20,071 | $3,805,862 | |
| 7 | AMGN |
Amgen Inc
|
10,242 | $3,708,831 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
24,093 | $3,043,907 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,640,343 | 42,284 | Shares | Other | 2026-07-17 | |
| 2026-03-31 | $8,867,935 | 40,774 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $9,368,316 | 41,001 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $9,408,163 | 40,633 | Shares | Other | 2025-11-03 | |
| 2025-06-30 | $7,604,664 | 40,969 | Shares | Other | 2025-07-15 | |
| 2025-03-31 | $8,870,238 | 42,336 | Shares | Other | 2025-05-01 | |
| 2024-12-31 | $6,683,829 | 37,613 | Shares | Other | 2025-01-16 | |
| 2024-09-30 | $7,423,272 | 37,590 | Shares | Other | 2024-10-23 | |
| 2024-06-30 | $5,486,409 | 31,987 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $5,695,904 | 31,279 | Shares | Other | 2024-04-11 | |
| 2023-12-31 | $3,925,234 | 25,329 | Shares | Other | 2024-01-23 | |
| 2023-09-30 | $4,136,116 | 27,748 | Shares | Other | 2023-10-19 | |
| 2023-06-30 | $2,703,087 | 20,063 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $4,179,317 | 26,224 | Shares | Other | 2023-04-27 | |
| 2022-12-31 | $3,161,575 | 19,563 | Shares | Other | 2023-01-27 | |
| 2022-09-30 | $2,370,147 | 17,660 | Shares | Other | 2022-10-26 | |
| 2022-06-30 | $2,280,550 | 14,890 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $2,375,883 | 14,656 | Shares | Other | 2022-05-05 | |
| 2021-12-31 | $1,992,545 | 14,716 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $1,416,871 | 13,135 | Shares | Other | 2021-10-27 | |
| 2021-06-30 | $1,476,596 | 13,109 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $1,334,243 | 12,329 | Shares | Other | 2021-05-11 | |
| 2020-12-31 | $1,236,831 | 11,543 | Shares | Other | 2021-01-25 | |
| 2020-09-30 | $1,244,477 | 14,208 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $1,336,228 | 13,610 | Shares | Other | 2020-07-31 | |
| 2020-03-31 | $952,450 | 12,501 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||